Combination between mean platelet volume and platelet distribution width to predict the prevalence and extent of coronary artery disease: Results from a large cohort study

Blood Coagulation and Fibrinolysis

Volumn 25, Issue 1, 2014, Pages 86-91

  De Luca, Giuseppe ^a   Secco, Gioel G ^a   Verdoia, Monica ^a   Cassetti, Ettore ^a   Schaffer, Alon ^a   Coppo, Lorenzo ^a   Marino, Paolo ^a  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE;

AGED; ANGIOCARDIOGRAPHY; ARTERIAL WALL THICKNESS; ARTICLE; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; CORONARY BLOOD VESSEL; DIABETES MELLITUS; ERYTHROCYTE COUNT; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OBESITY; PREVALENCE; PRIORITY JOURNAL; THROMBOCYTE; THROMBOCYTE COUNT; THROMBOCYTE VOLUME; THROMBUS;

AGED; BLOOD PLATELETS; CAROTID INTIMA-MEDIA THICKNESS; COHORT STUDIES; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; FEMALE; HUMANS; ITALY; MALE; MEAN PLATELET VOLUME; PLATELET COUNT; PREVALENCE; PROGNOSIS; RISK FACTORS;

EID: 84893668395     PISSN: 09575235     EISSN: 14735733     Source Type: Journal    
DOI: 10.1097/MBC.0b013e32836577a8     Document Type: Article

References (34)

1. Tsiara S, Elisaf M, Jagroop IA, Mikhailidis DP. Platelets as predictors of vascular risk: is there a practical index of platelet activity? Clin Appl Thromb Hemost 2003; 9:177-190.
2. Broadley AJ, Gapper P, Schmitt M, Frenneaux MP. Supine rest reduces platelet activation and aggregation. Platelets 2003; 14:3-7.
3. De Luca G, Bellandi F, Huber K, Noc M, Petronio AS, Arntz HR, et al. Early glycoprotein IIb-IIIa inhibitors in primary angioplasty-abciximab long-term results (EGYPT-ALT) cooperation: individual patient's data meta-analysis. J Thromb Haemost 2011; 9:2361-2370.
4. De Luca G, Smit JJ, Ernst N, Suryapranata H, Ottervanger JP, Hoorntje JC, et al. Impact of adjunctive tirofiban administration on myocardial perfusion and mortality in patients undergoing primary angioplasty for ST-segment elevation myocardial infarction. Thromb Haemost 2005; 93:820-823.
5. Navarese EP, Verdoia M, Schaffer A, Suriano P, Kozinski M, Castriota F, et al. Ischaemic and bleeding complications with new, compared to standard, ADP-antagonist regimens in acute coronary syndromes: a metaanalysis of randomized trials. QJM 2011; 104:561-569.
6. De Luca G, Navarese EP, Cassetti E, Verdoia M, Suryapranata H. Metaanalysis of randomized trials of glycoprotein IIb/IIIa inhibitors in high-risk acute coronary syndromes patients undergoing invasive strategy. Am J Cardiol 2011; 107:198-203.
7. Coban E, Bostan F, Ozdogan M. The mean platelet volume in subjects with impaired fasting glucose. Platelets 2006; 17:67-69.
8. Hekimsoy Z, Payzin B, Ornek T, Kandogan G. Mean platelet volume in type diabetic patients. J Diabetes Complic 2004; 18:173-176.
9. Brown AS, Hong Y, de Belder A, Beacon H, Beeso J, Sherwood R. Megakaryocyte ploidy and platelet changes in human diabetes and atherosclerosis. Arterioscler Thromb Vasc Biol 1997; 17:802-807.
10. Sharpe PC, Trinick T. Mean platelet volume in diabetes mellitus. QJM 1993; 86:739-742.
11. Nadar SK, Blann AD, Kamath S, Beevers DG, Lip GY. Platelet indexes in relation to target organ damage in high-risk hypertensive patients. A substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT). J Am Coll Cardiol 2004; 44:415-422.
12. Coban E, Ozdogan M, Yazcoglu G, Akcit F. The mean platelet volume in patients with obesity. Int J Clin Pract 2005; 59:981-982.
13. Ihara A, Kawamoto T, Matsumoto K, Shouno S, Hirahara C, Morimoto T, Noma Y. Relationship between platelet indexes and coronary angiographic findings in patients with ischemic heart disease. Pathophysiol Haemost Thromb 2006; 35:376-379.
14. Tavil Y, Sen N, Yazici HU, Hizal F, Abaci A, Cengel A, et al. Mean platelet volume in patients with metabolic syndrome and its relationship with coronary artery disease. Thromb Res 2007; 120:245-250.
15. De Luca G, Santagostino M, Secco GG, Cassetti E, Giuliani L, Franchi E, et al.Mean platelet volume and the extent of coronary artery disease: results from a large prospective study. Atherosclerosis 2009; 206:292-297; Feb 20.
16. Brown AS, Hong Y, de Belder A, Beacon H, Beeso J, Sherwood R, et al. Megakaryocyte ploidy and platelet changes in human diabetes and atherosclerosis. Arterioscler Thromb Vasc Biol 1997; 17:802-807.
17. Crescente M, Di Castelnuovo A, Iacoviello L, Vermylen J, Cerletti C, de Gaetano G. Response variability to aspirin as assessed by the platelet function analyzer (PFA)-100. A systematic review. Thromb Haemost 2008; 99:14-26.
18. Velik-Salchner C, Maier S, Innerhofer P, Streif W, Klingler A, Kolbitsch C, Fries D. Point-of-care whole blood impedance aggregometry versus classical light transmission aggregometry for detecting aspirin and clopidogrel: the results of a pilot study. Anesth Analg 2008; 107:1798- 1806.
19. De Luca G, Secco GG, Santagostino M, Venegoni L, Iorio S, Cassetti E, et al., Novara Atherosclerosis Study Group (NAS). Uric acid does not affect the prevalence and extent of coronary artery disease. Results from a prospective study. Nutr Metab Cardiovasc Dis 2012; 22:426-433.
20. De Luca G, van 't Hof AW, Ottervanger JP, Hoorntje JC, Gosselink AT, Dambrink JH, et al. Ageing, impaired myocardial perfusion, and mortality in patients with ST-segment elevation myocardial infarction treated by primary angioplasty. Eur Heart J 2005; 26:662-666.
21. Thaulow E, Erikssen J, Sandvik L, Stormorken H, Cohn PF. Blood platelet count and function are related to total and cardiovascular death in apparently healthy men. Circulation 1991; 84:613-617.
22. Kamath S, Blann AD, Lip GY. Platelet activation: assessment and quantification. Eur Heart J 2001; 22:1561-1571.
23. Martin JF, Trowbridge EA, Salmon G, Plumb J. The biological significance of platelet volume: its relationship to bleeding time, thromboxane B2 production and megakaryocyte nuclear DNA concentration. Thromb Res 1983; 32:443-460.
24. Halbmayer WM, Haushofer A, Radek J, Scho? n R, Deutsch M, Fischer M. Platelet size, fibrinogen and lipoprotein(a) in coronary heart disease. Coron Artery Dis 1995; 6:397-402.
25. McCabe DJ, Harrison P, Sidhu PS, Brown MM, Machin SJ. Circulating reticulated platelets in the early and late phases after ischaemic stroke and transient ischaemic attack. Br J Haematol 2004; 126:861-869.
26. Smith NM, Pathansali R, Bath PM. Altered megakaryocyte- platelethaemostatic axis in patients with acute stroke. Platelets 2002; 13:113- 120.
27. Senaran H, Ileri M, Altinbas A, Kosar A, Yetkin E, Ozturk M, et al. Thrombopoietin and mean platelet volume in coronary artery disease. Clin Cardiol 2001; 24:405-408.
28. Korovesis S, Fredericks S, Holt D, Toutouzas P, Kaski JC, Webb-Peploe MM, Katritsis D. Release of platelet activation markers during coronary angioplasty. Coron Artery Dis 2000; 11:391- 398.
29. van der Planken MG, Vertessen FJ, Vertommen J, Engelen W, Berneman ZN, De Leeuw I. Platelet prothrombinase activity, a final pathway platelet procoagulant activity, is overexpressed in type 1 diabetes: no relationship with mean platelet volume or background retinopathy. Clin Appl Thromb Hemost 2000; 6:65-68.
30. Kario K, Matsuo T, Nakao K. Cigarette smoking increases the mean platelet volume in elderly patients with risk factors for atherosclerosis. Clin Lab Haematol 1992; 14:281-287.
31. Papanas N, Symeonidis G, Maltezos E, Mavridis G, Karavageli E, Vosnakidis T, et al. Mean platelet volume in patients with type 2 diabetes mellitus. Platelets 2004; 15:475-478.
32. Coban E, Ozdogan M, Yazicioglu G, Akcit F. The mean platelet volume in patients with obesity. Int J Clin Pract 2005; 59:981-982.
33. Nadar S, Blann AD, Lip GY. Platelet morphology and plasma indices of platelet activation in essential hypertension: effects of amlodipine-based antihypertensive therapy. Ann Med 2004; 36:552-557.
34. De Luca G, Santagostino M, Secco GG, Cassetti E, Giuliani L, Coppo L, et al. Platelet-large cell ratio and the extent of coronary artery disease: results from a large prospective study. J Thromb Thrombolysis 2010; 30:426-433.